Ọrịa coronavirus ọhụrụ ebibiela ihe a kpọrọ mmadụ afọ atọ ka ọ dị ugbu a.Kemgbe Disemba 2022, a kagbuola nnwale nucleic acid n'ọtụtụ ebe n'ofe China, agaghịkwa enyocha akwụkwọ nnwale nucleic acid na-adịghị mma maka COVID-19.China abanyela n'oge nke na-efe efe na-ebikọ ọnụ.Iche ihu ọnụ ọgụgụ kachasị elu nke ọrịa, otu esi emeziwanye ihe mgbochi na ịbụ onye mbụ na-ahụ maka ahụike nke gị abụrụla isiokwu na-emetụta ọha mmadụ niile.

Dị ka uru ọgwụ ọdịnala ndị China na mgbochi na ịchịkwa ọrịa na-efe efe na-esiwanye ike, "Ganoderma lucidum", nke nwere mmetụta nke ịkwalite mgbochi na ịnọgide na-enwe nguzozi nke ọrụ niile, emeela nke ọma na mgbochi na ịchịkwa ọrịa a.

Yabụ, na-eme yaGanoderma lucidumnwere mmetụta mgbochi ọ bụla na coronavirus ọhụrụ ahụ?Ndị ọrịa nwere COVID-19 nwere ike iri nriGanoderma luciduminwe mmetụta dị mma na ahụ?Ọtụtụ nsonaazụ nyocha na nso nso a na-enye anyị ihe akaebe dị mma.

N'April 2020, akwụkwọ akụkọ agụmakwụkwọ mba ụwaMoleculesE bipụtara "Mkpịsị Ike Bioactive sitere na Fungi dị ka ndị Candidates maka Protease Inhibitors na Immunomodulators itinye akwụkwọ maka Coronaviruses".

Akwụkwọ a na-enyocha nchọpụta na ọganihu nyocha nke ogige ndị na-arụ ọrụ sitere n'okike nke fungi na-egbochi nje virus immunodeficiency (HIV) protease.Ọ na-atụ aro na-arụsi ọrụ ike ogige nke dịkwa ka usoro ha, karịsịaGanoderma lucidum(triterpenoids, polysaccharides na obere protein molekụla) na-arụ ọrụ dị mkpa n'igbochi nje nke nje virus (HIV).

Ọmụmụ ihe a na-enye onye nwere ike itinye ọgwụ maka mgbochi na ọgwụgwọ nke coronaviruses, nke enwere ike iji n'ọdịnihu iji gbochie na ịgwọ ọrịa coronavirus, ọkachasị maka mgbochi na ọgwụgwọ nke ọrịa coronavirus ọhụrụ.

Na 2021, “Agam n'ihu nke National Academy of Sciences (PNAS) 2021 Vol.118 No.5″ bipụtara otu edemede “Nchọpụta nke ndị na-egbochi ọrịa coronavirus ọhụrụ sitere na ọgwụ edepụtara na ọgwụ herbal”.Nnyocha ahụ chọpụtara naGanoderma lucidumMwepụta mmiri nwere ike igbochi ọrịa coronavirus ọhụrụ (SARS-Cov-2) ma na vivo na in vitro.

Mmiri ọgwụ ahịhịa nke China (1.0 g/20 ml, 5%) naGanoderma lucidumpolysaccharide RF3 (0.25 mg / ml, 0.025%).IC50 = ọkara mgbochi (nje virus) dose;CC50=ọkara ọgwụ na-egbu egbu

Nsonaazụ gosiri naGanoderma lucidumpolysaccharide RF3 (2μg/ml) nwere mmetụta antiviral dị ịrịba ama na SARS-Cov-2 omenala in vitro, ma ọ ka nwere ọrụ mgbochi mgbe etinyere ya na ugboro 1280.Mana ọ nweghị nsí na sel Vero E6 nke nje virus.

(A) Ndị nyocha hụrụ mmetụta mgbochi-sars-cov-2 nke ọgwụ na mpụta na hamsters.N'ụbọchị 0, hamsters butere ọrịa intranasal nke SARS-CoV-2.Mgbe nke ahụ gasịrị, a na-enye ndị hamsters ọnụ ọgwụ (30mg / kg / d) na ọgwụ ndị China omenala (200mg / kg / d), ugboro abụọ / d, na ibu viral na ngụgụ nke hamsters na-atụle mgbe ụbọchị 3 gasịrị ( n = 5), * P <0.05;* * P <0.005 (B) Mgbanwe ịdị arọ nke ahụ mgbe ọgwụgwọ 3-d gasịrị, N = 5 na otu ule, N = 6 n'ime otu njikwa.Nsonaazụ gosipụtara na e jiri ya tụnyere ndị na-ahụ maka ọrịa, nchịkwa ọnụ nkeGanoderma lucidumpolysaccharide RF3 nwere ike belata ibu viral (ọdịnaya) na ngụgụ nke hamsters bu nje SARS-Cov-2, na ụmụ anụmanụ adalataghị ibu n'oge ule ahụ.Nnwale mgbochi nje na vivo na in vitro gosipụtara nke ahụGanoderma lucidumpolysaccharide RF3 gbochiri ọrịa SARS-Cov-2 nke ukwuu.

Na Febụwarị 2020, Prọfesọ Sun Guifan, osote onye isi oche kọmitii ọkachamara nri nri nke China Nutrition and Health Food Association, na Institute of Preventive Medicine nke Mahadum Ahụike China, wepụtara akụkọ n'ihu ọha "usoro usoro sayensị nke abụọ ama ama na enyemaka ziri ezi. na mgbochi na ọgwụgwọ ọrịa coronavirus ọhụrụ n'ihe gbasara nri nri - ọrụ nke mgbakwunye nri”, mara ọkwa ọha na eze ụdị nri iri na abụọ nke nwere ike inye aka gbochie ma gwọọ ọrịa coronavirus ọhụrụ, gụnyereGanoderma lucidum, ọgwụ ahịhịa ọdịnala ndị China!

N'ime akụkọ ahụ, Prọfesọ Sun kwuru n'ụzọ doro anya naGanoderma lucidumnwere mmetụta na-akpali akpali nke na-alụso ọrịa ọgụ, nke nwere ike imetụta ikike ya ịlụso nje bacteria na nje virus ọgụ ozugbo.Laboratory cell ọmụmụ egosiwo na Reishi wepụ nwere ike kwụsị ma ọ bụ mee ka uto nke influenza nje, HIV, ịba ọcha n'anya B na ọtụtụ ndị ọzọ nje, reversing afọ metụtara mbelata na dịghịzi usoro ọrụ.

Prọfesọ Zhi-Bin Lin nke Peking University Health Science Center, onye lekwasịrị anya na nyocha ọgwụ nkeGanoderma lucidumn'ihi na ihe karịrị afọ 50, ẹkenam antiviral mmetụta na usoro nkeGanoderma lucidumna isiokwu "Mmetụta Antiviral nkeGanoderma lucidum” bipụtara na njedebe nke 2020, na-arụtụ aka na nke ahụGanoderma lucidum, karịsịa triterpenes dị n'ime yaGanoderma lucidum, nwere mmetụta mgbochi na ụdị nje dị iche iche.

Prọfesọ Zhi-Bin Lin buru ụzọ nyochaa usoro nke mmetụta antiviral nkeGanoderma lucidum, nke gụnyere igbochi mgbasa ozi ma ọ bụ ntinye nke nje na sel, na-egbochi imechi nje virus, igbochi ọrụ nke enzymes (dị ka reverse transcriptase na protease) chọrọ maka njikọ nje na sel, na igbochi nje virus DNA ma ọ bụ RNA replication maGanoderma lucidumenweghị nsí na-anabata sel ma nwee mmetụta synergistic na ngwakọta na ọgwụ mgbochi ama ama.

Isiokwu kwukwara na-adakarị irè nkeGanoderma lucidumon viral ọrịa nwere ike tumadi metụtara dịghịzi ụkpụrụ mmetụta nkeGanoderma lucidum, mgbochi oxidation na free radical scavenging mmetụta nkeGanoderma lucidum, na mmetụta nchebe nkeGanoderma lucidumna akụkụ na anụ ahụ.

Nnyocha ọgbara ọhụrụ gosiri naGanoderma lucidumbara ụba n'ọtụtụ ihe na-arụ ọrụ, nke bụ "onye ozi" maka ịkwalite mgbochi.

N'ikwu okwu n'ozuzu, ka ọdịnaya nke ihe ndị na-arụ ọrụ na-arụ ọrụ dị elu, mmetụta dị mma nke ịkwalite mgbochi.

N'ihe dị ka 2017, GanoHerb na Fujian Provincial Center for Disease Control and Prevention jikọrọ aka kwalite ọrụ nyocha na "Mmetụta nkeGanoderma LucidumGranules na arụ ọrụ mgbochi."E kewara ụmụ oke ahụ ụzọ ise, e nyere ha doses dị iche icheGanoderma lucidumgranules (nke GanoHerb Technology (Fujian) Corporation si kwuo.

Site n'ịtụle otu dose nke ọ bụla nke ihe nlele ahụ na ndị na-ahụ maka njikwa, a chọpụtara na: ① Otu ihe atụ dị elu na-eme ka mmụba nke lymphocytes splin mouse na-ebute site na ConA na ụdị hypersensitivity nke ụmụ oke na-ebute site na DNFB;② Otu ndị na-ajụ ase na ndị dị elu na-eme ka ikike ọgbọ nke antibody dịkwuo elu, ìgwè dị elu na-abawanye ọkwa nke hemolysin serum na ụmụ oke;③ Otu ihe atụ dị elu mere ka ọrụ mkpụrụ ndụ NK dị na ụmụ oke dịkwuo elu.

Nkwubi okwu sitere na ule a bụ na Ganoderma granules chepụtara yaGanoderma lucidumwepụ naGanoderma dị nrowepụ nwere ọrụ nke ịkwalite mgbochi.Dị ka ụlọ ọrụ na-eduga na-elekwasị anya na ụlọ ọrụ ahụike Ganoderma, kemgbe ntiwapụ nke ọrịa ahụ na 2020, GanoHerb enyela ngụkọta nke 9.126 nde yuan na ego na ihe gụnyere gụnyere.Ganoderma lucidummmanụ spore,Ganoderma lucidumspore ntụ ntụ naGanoderma lucidumwepụta iji nyere ndị ọrụ ahụike nọ n'ihu na ndị ọrụ ndị ọzọ aka imeziwanye ihe mgbochi ha ma wuo usoro nchekwa dị mma ọnụ.Ọ bụ kpọmkwem n'ihi ọrụ a na ntinye aka a ịgba mbọ ịlụso ọrịa ọgụ na 2021, GanoHerb Technology (Fujian) Corporation., onye enyemaka nke GanoHerb Group, nyere onyinye "Fujian Province Advanced Private Enterprise in Fighting against the Novel Coronary Pneumonia. Ntiwapụ ọrịa".

Oge asọmpi maka mgbochi abịala.Ị kwakọbagoro na GanoHerb organicGanodermanke na-ewusi mgbochi ike ma na-achịkwa ume ike?